Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBNP versus nitroglycerin in acute myocardial infarction complicated by heart failure
ChiCTR1900022010Phase 4Not yet recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Apr 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of nesiritide and nitroglycerin in myocardial infarction (MI) and heart failure (HF) (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoint: major adverse cardiac events. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
nesiritidenitroglycerin
03
Conditions
myocardial infarction (MI)heart failure (HF)
Beyond the preview
Go deeper on ChiCTR1900022010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022010.